These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 570253

  • 1. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A, Jenner P, Theodorou A, Marsden CD.
    Nature; 1979 Mar 01; 278(5699):59-61. PubMed ID: 570253
    [No Abstract] [Full Text] [Related]

  • 2. Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1980 May 02; 63(2-3):135-44. PubMed ID: 6103813
    [Abstract] [Full Text] [Related]

  • 3. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Eur J Pharmacol; 1980 May 02; 63(2-3):145-57. PubMed ID: 6103814
    [Abstract] [Full Text] [Related]

  • 4. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
    Dyer RG, Murugaiah K, Theodorou A, Clow A, Jenner P, Marsden CD.
    Life Sci; 1981 Jan 12; 28(2):167-74. PubMed ID: 6114373
    [No Abstract] [Full Text] [Related]

  • 5. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 12; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 6. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C, De Lucia R, Bernardi MM, Aizenstein ML.
    Eur J Pharmacol; 1985 May 28; 112(1):11-6. PubMed ID: 4040467
    [Abstract] [Full Text] [Related]

  • 7. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 28; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 8. Neuroleptic drugs and the dopamine hypothesis.
    Clow A, Jenner P, Theodorou A, Marsden CD.
    Lancet; 1979 Apr 28; 1(8122):934. PubMed ID: 86713
    [No Abstract] [Full Text] [Related]

  • 9. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Sep 01; 32(17):2495-9. PubMed ID: 6684429
    [Abstract] [Full Text] [Related]

  • 10. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL, Cross AJ, Longden A, Owen F, Poulter M.
    Neuropharmacology; 1979 Jul 01; 18(7):643-5. PubMed ID: 573871
    [No Abstract] [Full Text] [Related]

  • 11. Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to rats.
    Murugaiah K, Fleminger S, Hall MD, Theodorou A, Jenner P, Marsden CD.
    Neuropharmacology; 1984 Jun 01; 23(6):599-609. PubMed ID: 6540376
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O, Roncada P, Dall'Olio R, Montanaro N.
    Brain Res; 1988 Jul 12; 455(2):390-3. PubMed ID: 2969768
    [Abstract] [Full Text] [Related]

  • 13. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
    Clow A, Theodorou A, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1980 Jul 12; 69(3):227-33. PubMed ID: 6774362
    [Abstract] [Full Text] [Related]

  • 14. Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 months.
    Murugaiah K, Theodorou A, Jenner P, Marsden CD.
    Neuroscience; 1983 Nov 12; 10(3):811-9. PubMed ID: 6685826
    [Abstract] [Full Text] [Related]

  • 15. Dopamine receptor sensitivity after repeated morphine administrations to rats.
    Kuschinsky K.
    Life Sci; 1975 Jul 01; 17(1):43-8. PubMed ID: 167254
    [No Abstract] [Full Text] [Related]

  • 16. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
    Murugaiah K, Theodorou A, Clow A, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1985 Jul 01; 86(1-2):228-32. PubMed ID: 3927361
    [Abstract] [Full Text] [Related]

  • 17. Changes in dopamine receptors in mouse striatum following morphine treatments.
    de la Baume S, Patey G, Marçais H, Protais P, Costentin J, Schwartz JC.
    Life Sci; 1979 Jun 18; 24(25):2333-42. PubMed ID: 573360
    [No Abstract] [Full Text] [Related]

  • 18. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G, Porceddu ML, Spano PF, Gessa GL.
    Brain Res; 1977 Jul 15; 130(2):374-82. PubMed ID: 884534
    [No Abstract] [Full Text] [Related]

  • 19. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG, Uretsky NJ.
    J Pharmacol Exp Ther; 1982 Jun 15; 221(3):650-5. PubMed ID: 7201019
    [No Abstract] [Full Text] [Related]

  • 20. The effect of bradykinin on central dopamine receptors.
    Przesmycki K, Kleinrok Z.
    Pol J Pharmacol Pharm; 1976 Jun 15; 28(6):673-8. PubMed ID: 1034925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.